tiprankstipranks
Biolase Inc (BIOLQ)
:BIOLQ
US Market

BIOLASE (BIOLQ) Financial Statements

Compare
1,634 Followers

BIOLASE Financial Overview

BIOLASE's market cap is currently $318.40K. The company's EPS TTM is $-7.846; its P/E ratio is ―; BIOLASE is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 16.72M$ 15.91M$ 16.53M$ 6.17M$ 14.29M
Operating Income$ -17.90M$ -25.34M$ -15.80M$ -18.50M$ -15.62M
EBITDA$ -15.02M$ -25.28M$ -12.32M$ -13.84M$ -16.59M
Net Income$ -20.63M$ -28.63M$ -15.53M$ -16.83M$ -17.86M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 35.10M$ 38.19M$ 55.25M$ 41.02M$ 31.85M
Total Debt$ 14.82M$ 15.05M$ 15.05M$ 17.96M$ 13.47M
Net Debt$ 8.25M$ 10.87M$ -14.92M$ 396.00K$ 7.37M
Total Liabilities$ 33.15M$ 33.30M$ 30.08M$ 31.00M$ 27.50M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -15.23M$ -30.49M$ -17.42M$ -12.89M$ -12.95M
Operating Cash Flow$ -14.10M$ -26.76M$ -16.71M$ -12.79M$ -12.75M
Investing Cash Flow
Financing Cash Flow
Currency in USD

BIOLASE Earnings and Revenue History

BIOLASE Debt to Assets

BIOLASE Cash Flow

BIOLASE Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis